Cresset Asset Management LLC cut its position in shares of Relx Plc (NYSE:RELX - Free Report) by 82.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 19,123 shares of the technology company's stock after selling 90,266 shares during the quarter. Cresset Asset Management LLC's holdings in Relx were worth $869,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of RELX. Franklin Resources Inc. grew its holdings in shares of Relx by 3.3% during the third quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock valued at $873,000 after buying an additional 588 shares in the last quarter. Kathmere Capital Management LLC boosted its position in Relx by 7.2% during the fourth quarter. Kathmere Capital Management LLC now owns 48,141 shares of the technology company's stock valued at $2,187,000 after purchasing an additional 3,228 shares during the last quarter. Park Avenue Securities LLC boosted its position in Relx by 48.3% during the fourth quarter. Park Avenue Securities LLC now owns 61,173 shares of the technology company's stock valued at $2,778,000 after purchasing an additional 19,912 shares during the last quarter. Heritage Family Offices LLP boosted its position in Relx by 15.8% during the fourth quarter. Heritage Family Offices LLP now owns 24,632 shares of the technology company's stock valued at $1,119,000 after purchasing an additional 3,366 shares during the last quarter. Finally, Ritholtz Wealth Management boosted its position in Relx by 0.5% during the fourth quarter. Ritholtz Wealth Management now owns 148,234 shares of the technology company's stock valued at $6,733,000 after purchasing an additional 781 shares during the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the company. StockNews.com cut Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Relx has a consensus rating of "Buy".
Get Our Latest Analysis on Relx
Relx Stock Down 3.8%
NYSE:RELX opened at $51.79 on Tuesday. The stock's fifty day moving average price is $50.66 and its two-hundred day moving average price is $48.75. Relx Plc has a 52-week low of $42.77 and a 52-week high of $55.21. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a market cap of $95.86 billion, a price-to-earnings ratio of 27.85, a P/E/G ratio of 2.73 and a beta of 0.86.
Relx Increases Dividend
The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. This is an increase from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is 59.68%.
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.